Trial intelligence / Profile preview

Comparison of thrombolytic therapy with Alteplase and Tenecteplase in stroke

IRCT20241023063472N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Feb 2025
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of tissue-plasminogen activator and tenecteplase in stroke (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Feb 2025; status: completed.

02

Drugs

tissue-plasminogen activatortenecteplase
03

Conditions

stroke

Beyond the preview

Go deeper on IRCT20241023063472N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241023063472N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call